SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-10-001109
Filing Date
2010-04-16
Accepted
2010-04-15 17:55:54
Documents
1
Group Members
JAMES T. MICELILYNN BOOKER

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 cuxhaven_sc13da2-immunosyn.htm SC 13D/A 106299
  Complete submission text file 0001437749-10-001109.txt   108344
Mailing Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037 858-200-2320
IMMUNOSYN CORP (Subject) CIK: 0001375623 (see all company filings)

IRS No.: 205322896 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82677 | Film No.: 10753126
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O THELEN REID ATTN: CHRISTA VON LATTA 900 THIRD AVENUE NEW YORK NY 10022
Business Address NUNLEY DAVIS JOLLEY CLUCK AELVOET LLP 1580 SOUTH MAIN STREET, SUITE 200 BOERNE TX 78006 (212) 895-2000
Cuxhaven Holdings Ltd (Filed by) CIK: 0001386888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A